Experts suggest that Max Healthcare’s recent rally may not be over, despite failing to maintain a fresh record high. Traders could buy the stock at present or on dips towards Rs 450-500 with a potential target of Rs 750-1,000 in the next six months, they say. On the weekly charts, the stock broke out from a trendline and has been making higher highs and higher lows for the past five weeks. Although some consolidation could occur as it trades around overbought levels, the Relative Strength Index is 78.2 and the MACD is bullish.
RBI rate cut to pressure bank margins, NBFCs brace for liquidity strain
RBI’s 25-bps rate cut, its first in five years, pressures private banks’ NIMs while public banks remain stable. NBFCs may see funding relief, but liquidity